Results 251 to 260 of about 102,210 (307)
Case - Hematuria and uroepithelial thickening Anticoagulation-induced suburothelial hemorrhage. [PDF]
Can Urol Assoc JNiakani S +3 more
europepmc +1 more source
Deep Vein Thrombosis Secondary to Brucellosis: An Uncommon Infectious Cause of Venous Thrombosis. [PDF]
Case Rep Infect DisDakdouki GE +5 more
europepmc +1 more source
Drug-Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High-Throughput Screening of Clopidogrel and Oral Anticoagulants. [PDF]
Pharmacoepidemiol Drug SafD'Amico AM +9 more
europepmc +1 more source
Portal Hypertension &Cirrhosis, Volume 5, Issue 3, Page 304-305, September 2026.
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Internal Medicine, 2005
Warfarin or not warfarin? That is the question.Each day, physicians who treat elderly patients, especially octogenar-ians, consider this dilemma. Benefits of warfarin are well known inpatients 75 years of age or older. However, compared with youngerpatients, this group is at higher risk for intracranial hemorrhage andother types of warfarin-associated ...
Margaret C. Fang, Daniel E. Singer
openaire +2 more sources
Warfarin or not warfarin? That is the question.Each day, physicians who treat elderly patients, especially octogenar-ians, consider this dilemma. Benefits of warfarin are well known inpatients 75 years of age or older. However, compared with youngerpatients, this group is at higher risk for intracranial hemorrhage andother types of warfarin-associated ...
Margaret C. Fang, Daniel E. Singer
openaire +2 more sources
Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, 2010 Background— Although warfarin is widely recommended to prevent atrial fibrillation-related thromboembolism, many eligible patients do not take warfarin. The objective of this study was to describe factors associated with warfarin
Daniel Singer +2 more
exaly +2 more sources
Pediatric Pathology & Molecular Medicine, 2003
A 34-year-old gravida 2 para 1 (1001) mother was on prophylactic anticoagulation therapy because of pulmonary emboli postabdominal surgery. The pregnancy was terminated at 25 weeks' gestation after ultrasound examination showed a mild hydrocephalus and a cardiac structural defect.
Kiat Yeong, Chan +2 more
openaire +2 more sources
A 34-year-old gravida 2 para 1 (1001) mother was on prophylactic anticoagulation therapy because of pulmonary emboli postabdominal surgery. The pregnancy was terminated at 25 weeks' gestation after ultrasound examination showed a mild hydrocephalus and a cardiac structural defect.
Kiat Yeong, Chan +2 more
openaire +2 more sources
Annual Review of Medicine, 2010
Warfarin is a drug with a narrow therapeutic index and a wide interindividual variability in dose requirement. Because it is difficult to predict an accurate dose for an individual, patients starting the drug are at risk of thromboembolism or bleeding associated with underdosing or overdosing, respectively.
Kamali F, Wynne H
openaire +3 more sources
Warfarin is a drug with a narrow therapeutic index and a wide interindividual variability in dose requirement. Because it is difficult to predict an accurate dose for an individual, patients starting the drug are at risk of thromboembolism or bleeding associated with underdosing or overdosing, respectively.
Kamali F, Wynne H
openaire +3 more sources